Marta Popeda
Overview
Explore the profile of Marta Popeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wisniewski K, Popeda M, Price B, Bienkowski M, Fahlstrom A, Drummond K, et al.
J Neurosurg
. 2023 Jan;
139(3):698-707.
PMID: 36640097
Objective: Delayed cerebral ischemia (DCI) is a serious complication of aneurysmal subarachnoid hemorrhage (aSAH), which is responsible for significant death and disability. The dynamic balance between the production and elimination...
12.
Peksa R, Kunc M, Bienkowski M, Popeda M, Biernat W
Pol J Pathol
. 2022 Nov;
73(2):159-165.
PMID: 36345953
Terminal deoxynucleotidyl transferase (TdT) is a unique type of DNA polymerase predominantly expressed in precursor lymphoid cells and acute lymphoblastic leukemia. It participates in the junctional diversity of T-cell receptors...
13.
Zapala L, Kunc M, Sharma S, Peksa R, Popeda M, Biernat W, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(7):4131-4139.
PMID: 36042047
Purpose: The study aimed to determine the expression of VISTA and TOX within venous tumor thrombus and primary clear cell renal cell carcinoma (ccRCC) and to assess their prognostic value....
14.
Muchlinska A, Nagel A, Popeda M, Szade J, Niemira M, Zielinski J, et al.
Cell Mol Biol Lett
. 2022 Jun;
27(1):45.
PMID: 35690734
Background: Cancer-associated fibroblasts (CAFs) have been shown to support tumor development in a variety of cancers. Different markers were applied to classify CAFs in order to elucidate their impact on...
15.
Nagel A, Popeda M, Muchlinska A, Sadej R, Szade J, Zielinski J, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454913
Background: Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the tumor microenvironment (TME). Estrogen receptor alpha 36 (ERα36), the alternatively spliced variant of ERα, is described as an...
16.
Zapala L, Kunc M, Sharma S, Peksa R, Popeda M, Biernat W, et al.
Urol Oncol
. 2022 Mar;
40(5):200.e1-200.e10.
PMID: 35346570
Backround: Renal cell carcinoma (RCC) frequently invades renal vein forming neoplastic thrombus. The expression of immune checkpoint receptors in RCC was addressed in multiple studies, but little is known about...
17.
Bednarz-Knoll N, Popeda M, Kryczka T, Kozakiewicz B, Pogoda K, Szade J, et al.
Br J Cancer
. 2021 Dec;
126(3):464-471.
PMID: 34857895
Background: Platelets support tumour progression. However, their prognostic significance and relation to circulating tumour cells (CTCs) in operable breast cancer (BrCa) are still scarcely known and, thus, merit further investigation....
18.
Nastaly P, Smentoch J, Popeda M, Martini E, Maiuri P, Zaczek A, et al.
J Pers Med
. 2021 Nov;
11(11).
PMID: 34834440
Tumor-to-stroma ratio (TSR) is a prognostic factor that expresses the relative amounts of tumor and intratumoral stroma. In this study, its clinical and molecular relevance was evaluated in prostate cancer...
19.
Kunc M, Popeda M, Biernat W, Senkus E
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638241
Estrogen receptor α (ERα) and progesterone receptor (PgR) are crucial prognostic and predictive biomarkers that are usually co-expressed in breast cancer (BC). However, 12-24% of BCs present ERα(+)/PgR(-) phenotype at...
20.
Markiewicz A, Topa J, Popeda M, Szade J, Skokowski J, Welnicka-Jaskiewicz M, et al.
Acta Biochim Pol
. 2021 Aug;
68(3):385-392.
PMID: 34432400
Breast cancer (BC) is a heterogeneous disease with different molecular subtypes, which can be defined by oestrogen (ER), progesterone (PR) and human epidermal growth factor (HER2) receptors' status as luminal,...